Extended vs short‐duration valganciclovir
CMV disease · solid organ transplant recipients
Extended probably leads to lower CMV disease compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.2 [0.12, 0.35]2 studies · 454 participantsModerate